Page 7 - Mark Macgregor News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Retsevmo, Keytruda and Jyseleca accepted for use by NHS Scotland - News - PharmaTimes

Medicines for colorectal, skin and ovarian cancers are among four newly approved treatements for use in NHS Scotland. The Scottish Medicines Consortium (SMC) announced it has accepted four new medicines for routine use from Monday including Encorafenib (Braftovi), hydrochloride (Ledaga), niraparib (Zejula) and Ravulizumab (Ultomiris). Encorafenib (Braftovi) was accepted for use along with the medicine cetuximab for the treatment of colorectal cancer in patients with a gene mutation called “BRAF V600”. It can be used when the cancer has spread elsewhere in the body after previously being t...

Hume Brophy continues senior hire spree with chair and digital strategy lead Hume Brophy has appointed industry stalwart and former chair of Hanover Communications and Blue Rubicon, Alastair Gornall, as the consultancy’s new chair, and Robin Hamman as group director of digital strategy. by Arvind Hickman Hume Brophy's new digital strategy director Robin Hamman and chair Alastair Gornall (inset). Photo: Dolly Clew Sign in to continue Register Limited Article Views (Excludes Subscriber Only Content) Select Newsletters (Excludes Subscriber Only Bulletins) Limited number of free email bulletins...

Medicines to help asthma and migraines among drugs approved for use in Scotland Updated: April 12 2021, 5.21pm The Scottish Medical Consortium have approved the use of four new drugs in Scotland (Andrew Milligan/PA) Sign up for our daily newsletter of the top stories in Courier country Thank you for signing up to The Courier daily newsletter Something went wrong - please try again later. Sign Up Four new medicines have been approved for use by NHS Scotland for severe asthma, migraines, heart failure and bone marrow cancer. The treatments were given the green light by the Scottish Medic...

Zolgensma, used to treat spinal muscular atrophy, costs almost £1.8 million per dose (Ben Birchall/PA) Sign up for our daily newsletter featuring the top stories from The Press and Journal. Thank you for signing up to The Press and Journal newsletter. Something went wrong - please try again later. Sign Up A medicine known as the most expensive in the world has been approved to treat a rare genetic disease in children through NHS Scotland. The Scottish Medicines Consortium (SMC) has given approval to Onasemnogene abeparvovec, sold under the brand name Zolgensma, for the treatment of sp...